METROPOLIS — Metropolis Healthcare Share Price
- IN₹107.59bn
- IN₹107.87bn
- IN₹16.46bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.11 | ||
| Price to Tang. Book | 33.41 | ||
| Price to Free Cashflow | 35.88 | ||
| Price to Sales | 6.54 | ||
| EV to EBITDA | 27.53 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.31% | ||
| Return on Equity | 13.36% | ||
| Operating Margin | 15.68% | ||
Financial Summary
| Year End 31st Mar | Unit | 2022 | 2023 | 2024 | 2025 | 2026 | 2027E | 2028E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 12,283.36 | 11,482.1 | 12,077.09 | 13,312.03 | 16,458.46 | n/a | n/a | 10.52% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +10.17 | -29.41 | +257.41 | -71.96 | +36.39 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Metropolis Healthcare Limited is engaged in providing diagnostic services to patients, healthcare providers, and corporates across India and Africa. It has a single operating segment, namely Pathology services. It is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, other pathological and radiological investigations. Its services include Pathology Testing Services, Corporate Wellness, Lab In Hospitals and Clinical Research Services. It serves a diverse customer base, including B2C (Business to Consumer), B2B (Business to Business), and institutional clients. It offers more than 4,000 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities. Its footprint spans 28 states, seven Union Territories.
Directors
- Last Annual
- March 31st, 2026
- Last Interim
- March 31st, 2026
- Incorporated
- November 10th, 2000
- Public Since
- April 15th, 2019
- No. of Employees
- 4,823
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 207,331,968

- Address
- 4th Floor, East Wing, Nirlon House,, Dr., MUMBAI, 400030
- Web
- https://www.metropolisindia.com/
- Phone
- +91 8422801801
- Auditors
- BSR & Co. LLP
Upcoming Events for METROPOLIS
Q1 2027 Metropolis Healthcare Ltd Earnings Release
Metropolis Healthcare Ltd Annual Shareholders Meeting
Q2 2027 Metropolis Healthcare Ltd Earnings Release
Similar to METROPOLIS
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Chandan Healthcare
National Stock Exchange of India
FAQ
As of Today at 13:03 UTC, shares in Metropolis Healthcare are trading at IN₹518.95. This share price information is delayed by 15 minutes.
Shares in Metropolis Healthcare last closed at IN₹518.95 and the price had moved by +27.55% over the past 365 days. In terms of relative price strength the Metropolis Healthcare share price has outperformed the S&P BSE 100 Index by +30.79% over the past year.
There is no consensus recommendation for this security.
Find out moreMetropolis Healthcare does not currently pay a dividend.
Metropolis Healthcare does not currently pay a dividend.
Metropolis Healthcare does not currently pay a dividend.
To buy shares in Metropolis Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹518.95, shares in Metropolis Healthcare had a market capitalisation of IN₹107.59bn.
Here are the trading details for Metropolis Healthcare:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: METROPOLIS
Based on an overall assessment of its quality, value and momentum Metropolis Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Metropolis Healthcare. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +14.44%.
As of the last closing price of IN₹518.95, shares in Metropolis Healthcare were trading +5.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Metropolis Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹518.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Metropolis Healthcare's management team is headed by:
- Sushil Shah - CHM
- Vijender Singh - CEO
- Danish Allana - CCO
- Ameera Shah - MDR
- Hemant Sachdev - NED





